Session Three-Four Panel Discussion: C-Peptide as Biomarker in Trials of T1D

About this Talk

PANELISTS: FDA (1 QM, 1 Physician), Industry, Academic (Clinical Trials), Physician

Moderators

Speaker TBD

Speaker TBD